Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Global Health has informed that the representatives of Investors/Analysts are scheduled to meet the Management of the Company on Tuesday, 28th March, 2023, as per the schedule attached in the intimation. No Unpublished Price Sensitive Information is proposed to be shared thereat.
The above information is a part of company’s filings submitted to BSE.